MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Supportive treatments for Ataxia, a Randomized Control Trial

MIA. Arain (Jamshoro, Pakistan)

Meeting: 2019 International Congress

Abstract Number: 237

Keywords: Ataxia: Treatment, Rehabilitation

Session Information

Date: Monday, September 23, 2019

Session Title: Ataxia

Session Time: 1:45pm-3:15pm

Location: Les Muses, Level 3

Objective: The objective of this study is to evaluate the effectiveness of supporting treatments that improve awareness and the quality of patient life and counsel them to maintain self sufficiency.

Background: Ataxia is a neurological disorder that can cause disturbance in performed of skilled movements such as coordination, walk, speech, and balance. In Ataxia, patients coordinated movements and balance can be disturbed. Poor limb coordination, slurred and slow speech and difficulty swallowing are common symptoms of Ataxia. Generally, it is not curable but its complications can be control by supportive treatments of rehabilitation, medications, and counselling. These supportive therapies enhance the quality of life and improve the physical disabilities of Parkinsonism patients.

Method: it is a Randomized, control single-blind trial study which is performed in Outpatient rehabilitation centre of Hyderabad Pakistan. Patients of ataxia were randomly selected to four week rehabilitation and counselling programmes and after 4 week control group start. Different complications of ataxia were analysed. The study outcomes of supportive therapies were measure Ataxia Rating scale after 4 week and 8 week

Results: Total 90 ataxia patients that come in age group of 25 -50 years were evaluated during initial study. In which, 41 were excluded & 27 individual declined to participate. Remaining 22 were included in study analysis. Mostly movement complications were observed in 84% and co-existing conditions of depression were also observed in 71% patients. Ataxia Impact scale find out the significant improvement in health and movement activities of group that included in  rehabilitation counselling interventions as compared to control group(p=0.003).

Conclusion: This study concluded that supported treatments which included rehabilitation and counselling can improve the health and relive from complication of ataxia in patients. However, further study is required to detect significant improvement after supportive non pharmacological therapies

To cite this abstract in AMA style:

MIA. Arain. Supportive treatments for Ataxia, a Randomized Control Trial [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/supportive-treatments-for-ataxia-a-randomized-control-trial/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/supportive-treatments-for-ataxia-a-randomized-control-trial/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley